Join us for this educational broadcast as a leading faculty delve into the groundbreaking advancements in the treatment of severe tricuspid regurgitation with the innovative Edwards EVOQUE Tricuspid Valve Replacement System. This session will feature an informative "Live in a Box" tricuspid replacement valve case by Prof. Jörg Hausleiter, provide a comprehensive analysis of the patient selection criteria, pre-procedural analysis, and latest clinical evidence associated with transcatheter tricuspid valve replacement (TTVR).

Chaired by Prof Philipp Lurz (University Medical Center Mainz, Mainz, DE) and Prof Wolfgang Rottbauer (Ulm University, Ulm, DE), this interactive broadcast will bring together a leading international faculty with experience of the EVOQUE System. Use this opportunity to get involved and ask your questions through live Q&A as well as interactive polls, which will be reviewed by thought-leading faculty members from across Europe.


4:00 PM - 5:10 PM (CEST)
Revolutionising the Treatment of Severe Tricuspid Regurgitation with the EVOQUE System

  • Session Opening - Philipp Lurz and Wolfgang Rottbauer  

  • TRISCEND II pivotal study results and patient selection criteria for the EVOQUE valve - Philipp Lurz  

  • Patient presentation and preparation - Jörg Hausleiter  

  • Imaging analysis and insights on multiplanar reconstruction (MPR) - Maria Körber  

  • Case featuring EVOQUE system - Jörg Hausleiter  

  • Initial experience with the EVOQUE systemSam Dawkins  

  • Wrap up and closing remarks - Philipp Lurz and Wolfgang Rottbauer


Learning Objectives

  • Showcase an EVOQUE system procedure from LMU Klinikum Großhadern and discuss  pre-procedural planning and procedural steps.

  • Share and discuss the latest clinical evidence for transcatheter tricuspid valve replacement (TTVR) using the EVOQUE system.

  • Learn about the patient selection criteria for the EVOQUE valve. 

  • Discuss live imaging and procedure analysis using MPR.

  • Hear from your peers about the initial experience with the EVOQUE system, required training and key challenges.

Target Audience

  • Interventional cardiologists

  • General cardiologists

  • Echocardiologists

  • Heart failure specialists


Philipp Lurz
Philipp Lurz

University Medical Center Mainz, Mainz, DE

Wolfgang Rottbauer
Wolfgang Rottbauer

Ulm University, Ulm, DE


Sam Dawkins
Sam Dawkins

John Radcliffe Hospital, Oxford, UK

Jörg Hausleiter
Jörg Hausleiter

Ludwig-Maximilians University, Munich, DE

Maria Körber
Maria Körber

University of Cologne, Cologne, DE

Ali Vazir
Ali Vazir

Royal Brompton Hospital, London, UK

Key References:

Kodali S,TRISCEND II Trial: A Randomized Trial of Transcatheter Tricuspid Valve Replacement in Patients with Severe Tricuspid Regurgitation. TCT 2023.   

Lukas S et al., 2-Year Outcomes Following Transcatheter Tricuspid Valve Replacement Using the EVOQUE System. J Am Coll Cardiol. 2023 Jun 20;81(24):2374-2376.  

Webb JG et al., Transcatheter Tricuspid Valve Replacement With the EVOQUE System: 1-Year Outcomes of a Multicenter, First-in-Human Experience. JACC Cardiovasc Interv. 2022 Mar 14;15(5):481-491.